Literature DB >> 11211225

Emergence of a high-level cefotaxime-resistant Streptococcus pneumoniae strain in New Zealand.

Maggie S Brett1.   

Abstract

An increase in the number of cefotaxime-resistant pneumococci referred for surveillance to a central laboratory in New Zealand occurred in 1997-1998. The MIC of cefotaxime for 113 of 216 cefotaxime-resistant isolates of Streptococcus pneumoniae referred was > or = 4 mg/L. Most of the 113 isolates exhibited the same antibiotic resistance pattern and belonged to serotype 19F. To investigate the genetic relatedness of the isolates, 48 serotype 19F pneumococci with varying susceptibility to cefotaxime were further typed by macro-restriction analysis by use of pulsed-field gel electrophoresis. These results suggested that a multiresistant 19F strain of S. pneumoniae with high-level cefotaxime resistance had emerged from a pre-existing serotype 19F strain.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11211225     DOI: 10.1099/0022-1317-50-2-173

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  1 in total

1.  Invasive pneumococcal disease in New Zealand 1998-2005: capsular serotypes and antimicrobial resistance.

Authors:  H M Heffernan; D R Martin; R E Woodhouse; J Morgan; T K Blackmore
Journal:  Epidemiol Infect       Date:  2007-05-17       Impact factor: 2.451

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.